Exact Mass: 379.0069254

Exact Mass Matches: 379.0069254

Found 66 metabolites which its exact mass value is equals to given mass value 379.0069254, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

2-Bromo-5-hydroxy-N-(4-hydroxyphenethyl)-4-methoxy-N-methylbenzamide

2-Bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide

C17H18BrNO4 (379.04191280000003)

6-Thioguanosine monophosphate

{[(2R,3S,4R,5R)-5-(2-amino-6-sulfanylidene-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7PS (379.03515440000007)

6-Thioguanosine monophosphate is a metabolite of tioguanine. Tioguanine, formerly thioguanine, is a drug that is used in the treatment of cancer. It belongs to the family of drugs called antimetabolites. It is a guanine analog. (Wikipedia) Norcodeine

PERFLUIDONE

C14H12F3NO4S2 (379.01598279999996)

8-Oxoguanosine 5-phosphate

C10H14N5O9P (379.0529124)

[2,3-e]-1,2-Thiazine-6-sulfonamide 1,1-Dioxide 1

2-methyl-3-[(morpholin-4-yl)methyl]-1,1-dioxo-2H-1lambda6-thieno[2,3-e][1,2]thiazine-6-sulfonamide

C12H17N3O5S3 (379.03303120000004)

Cyclopenthiazide

6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide

C13H18ClN3O4S2 (379.0427218)

C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

[(2R,5R)-5-(2-Amino-6-sulfanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,5R)-5-(2-Amino-6-sulphanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphoric acid

C10H14N5O7PS (379.03515440000007)

Pyridinium-3,5-biscarboxylic acid mononucleotide; P2CMN; Pyridin-1-ium-3,5-dicarboxylate mononucleotide; Pyridinium-3,5-biscarboxylate mononucleotide

C12H14NO11P (379.0304464)

Convolutamine B

C13H19Br2NO2 (378.9782434)

CHEMBL335822

C20H11Cl2N3O (379.02791360000003)

C16H18BrN3OS

C16H18BrN3OS (379.0353878)

eudistomin C

C16H18BrN3OS (379.0353878)

8-oxo-GMP

C10H14N5O9P (379.0529124)

cyclopenthiazide

C13H18ClN3O4S2 (379.0427218)

((4R,5R)-5-(4-Iodophenyl)-2-phenyl-4,5-dihydrooxazol-4-yl)methanol

C16H14INO2 (379.0069254)

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide

C17H18BrNO4 (379.04191280000003)

2-[3-(2,6-dichlorophenyl)sulfanyl-2,5-dimethylindol-1-yl]acetic acid

C18H15Cl2NO2S (379.020051)

Ethyl 8-bromo-4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate

C13H9BrF3NO4 (378.96670100000006)

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R,R)]-aminoacetate

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R*,R*)]-aminoacetate

C13H15Cl2N3O6 (379.033787)

ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

C17H15Cl2N3O3 (379.049042)

2-(3-BROMO-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C19H14BrN3O (379.03201740000003)

2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazole-4-carboxylic acid

C19H13N3O2S2 (379.0449158)

1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 5-bromo-1-(phenylsulfonyl)-

C14H10BrN3O3S (378.962621)

3-BROMO-1-(4-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1,4-DIAZEPAN-1-YL)PROPAN-1-ONE

C14H17BrF3N3O (379.0507008)

L-689,560

(2R,4S)-4-[[anilino(oxo)methyl]amino]-5,7-dichloro-1,2,3,4-tetrahydroquinoline-2-carboxylic acid

C17H15Cl2N3O3 (379.049042)

D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists

2,5-dibromopyridine-3-boronic acid pinacol ester

C11H16BBr2NO3 (378.9589896)

N-cyclopentyl-5-(4-iodophenyl)-2-methylpyrimidin-4-amine

C16H18IN3 (379.05454180000004)

N-(TRIISOPROPYLSILYL)-3,4-DIBROMOPYRROLE

C13H23Br2NSi (378.9966398)

Deoxyribonucleic acid sodium salt

C17H15BrFNO3 (379.02192720000005)

C13H9BrF3NO4

C13H9BrF3NO4 (378.96670100000006)

4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one

C13H9N5O5S2 (379.0045104)

2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide

C21H14ClNO2S (379.04337340000006)

3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.04325040000003)

3-Bromo-6-Phenyl-N-(Pyrimidin-5-Ylmethyl)imidazo[1,2-A]pyridin-8-Amine

C18H14BrN5 (379.04325040000003)

3-Bromo-5-Phenyl-N-(Pyrimidin-5-Ylmethyl)pyrazolo[1,5-A]pyridin-7-Amine

C18H14BrN5 (379.04325040000003)

3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.04325040000003)

Adenosine-5-(dithio)phosphate

C10H14N5O5PS2 (379.01739640000005)

2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one

C10H14N5O9P-2 (379.0529124)

N-acetyl-D-galactosamine 4,6-disulfate

C8H13NO12S2-2 (378.9879178)

p-Nitrophenyl-beta-glucoside 6-phosphate

C12H14NO11P-2 (379.0304464)

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxan-2-yl]methyl phosphate

C12H14NO11P-2 (379.0304464)

N-Hydroxyguanosine 5-phosphoric acid

C10H14N5O9P (379.0529124)

5-[(2,4-dichlorophenoxy)methyl]-N-(2-fluorophenyl)furan-2-carboxamide

C18H12Cl2FNO3 (379.0178234)

(2-Chloro-5-nitrophenyl)(4-(3-chlorophenyl)piperazin-1-yl)methanone

C17H15Cl2N3O3 (379.049042)

2-[[2-(4-Ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole

C16H17N3O2S3 (379.0482862)

Methyl 5-chloro-4-{[3-(4-chlorophenyl)acryloyl]amino}-2-methoxybenzoate

C18H15Cl2NO4 (379.03780900000004)

N-[(4-sulfamoylanilino)-sulfanylidenemethyl]-1,3-benzodioxole-5-carboxamide

C15H13N3O5S2 (379.0296608)

isopropyl 4-{[(4-bromo-1-ethyl-1H-pyrazol-5-yl)carbonyl]amino}benzoate

C16H18BrN3O3 (379.05314580000004)

Molybdopterin synthase intermediate

C10H14N5O7PS (379.03515440000007)

tetracenomycin D3(1-)

C20H11O8- (379.0453906)

A hydroxy monocarboxylic acid anion that is the conjugate base of tetracenomycin F1, obtained by deprotonation of the carboxy group.

methanesulfonic acid [(2R,5R)-2-(6-amino-2-chloro-9-purinyl)-4-hydroxy-5-(hydroxymethyl)-3-oxolanyl] ester

C11H14ClN5O6S (379.0353294)

4-chloro-N-(3-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)

2-[[3,4-Dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]amino]acetic acid

C16H13NO10 (379.0539438)

4-chloro-N-(5-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)

4-chloro-N-[(2S)-2-methyl-3-oxo-2H-indol-1-yl]-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)

6-Thioguanosine monophosphate

C10H14N5O7PS (379.03515440000007)

O-304

C16H11Cl2N3O2S (378.99490060000005)

O-304 is a first-in-class, orally available pan-AMPK activator, which increases AMPK activity by suppressing the dephosphorylation of pAMPK. O-304 exhibits a great potential as a agent to treat type 2 diabetes (T2D) and associated cardiovascular complications [1][2].